172 related articles for article (PubMed ID: 24708927)
1. CDP-choline attenuates scopolamine induced disruption of prepulse inhibition in rats: involvement of central nicotinic mechanism.
Uslu G; Savci V; Buyukuysal LR; Goktalay G
Neurosci Lett; 2014 May; 569():153-7. PubMed ID: 24708927
[TBL] [Abstract][Full Text] [Related]
2. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
4. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
Gurun MS; Parker R; Eisenach JC; Vincler M
Anesth Analg; 2009 May; 108(5):1680-7. PubMed ID: 19372354
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex.
Jones CK; Shannon HE
J Pharmacol Exp Ther; 2000 Sep; 294(3):1017-23. PubMed ID: 10945854
[TBL] [Abstract][Full Text] [Related]
6. Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors.
Suemaru K; Yasuda K; Umeda K; Araki H; Shibata K; Choshi T; Hibino S; Gomita Y
Br J Pharmacol; 2004 Jul; 142(5):843-50. PubMed ID: 15197106
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the alpha(7) nicotinic acetylcholine receptor in Wistar rats.
Kohnomi S; Suemaru K; Goda M; Choshi T; Hibino S; Kawasaki H; Araki H
Brain Res; 2010 Sep; 1353():152-8. PubMed ID: 20673759
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
9. Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Eur J Pharmacol; 2008 Jul; 589(1-3):315-22. PubMed ID: 18561911
[TBL] [Abstract][Full Text] [Related]
10. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
Larrauri JA; Burke DA; Hall BJ; Levin ED
Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
[TBL] [Abstract][Full Text] [Related]
11. CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.
Cavun S; Savci V
Fundam Clin Pharmacol; 2004 Oct; 18(5):513-23. PubMed ID: 15482372
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice.
Schreiber R; Dalmus M; De Vry J
Psychopharmacology (Berl); 2002 Jan; 159(3):248-57. PubMed ID: 11862357
[TBL] [Abstract][Full Text] [Related]
13. Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Koda K; Ago Y; Kawasaki T; Hashimoto H; Baba A; Matsuda T
Psychopharmacology (Berl); 2008 Feb; 196(2):293-301. PubMed ID: 17912499
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic mechanism underlying prepulse inhibition of the startle response in rats.
Bosch D; Schmid S
Neuroscience; 2008 Jul; 155(1):326-35. PubMed ID: 18571866
[TBL] [Abstract][Full Text] [Related]
15. The effect of centrally injected CDP-choline on respiratory system; involvement of phospholipase to thromboxane signaling pathway.
Topuz BB; Altinbas B; Yilmaz MS; Saha S; Batten TF; Savci V; Yalcin M
Respir Physiol Neurobiol; 2014 May; 195():50-8. PubMed ID: 24560778
[TBL] [Abstract][Full Text] [Related]
16. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
18. Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.
Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Labelle A; Knott V
Int J Psychophysiol; 2019 Nov; 145():70-82. PubMed ID: 30790597
[TBL] [Abstract][Full Text] [Related]
19. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750
[TBL] [Abstract][Full Text] [Related]
20. Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.
Cavun S; Savci V; Ulus IH
Fundam Clin Pharmacol; 2004 Feb; 18(1):71-7. PubMed ID: 14748757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
